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Abstract
This study investigated whether there was an association between splenectomy and pulmonary tuberculosis. This was a case–control study
using the database of the Taiwan National Health Insurance Programme. We identiﬁed 18 960 patients (aged 20 years or older) with newly
diagnosed pulmonary tuberculosis as the case group and 73 988 participants without pulmonary tuberculosis as the control group from
1998 to 2011. Both groups were matched for sex, age (per 5 years) and index year of pulmonary tuberculosis diagnosis. The risk of
pulmonary tuberculosis associated with splenectomy and other co-morbidities was estimated. After controlling for confounders,
multivariable logistic regression analysis showed that the odds of pulmonary tuberculosis were 1.91 in patients with splenectomy (95% CI
1.06–3.44), compared with the participants without splenectomy. Chronic obstructive pulmonary diseases (OR 3.07, 95% CI 2.94–3.21),
pneumoconiosis (OR 2.20, 95% CI 1.90–2.56), chronic kidney diseases (OR 1.49, 95% CI 1.33–1.67), diabetes mellitus (OR 1.57, 95% CI
1.50–1.64) and chronic liver diseases (OR 1.31, 95% CI 1.25–1.37) were associated with an increased risk of pulmonary tuberculosis. The
sub-analysis demonstrated that the odds of pulmonary tuberculosis were 4.81 (95% CI 2.31–10.0) for patients co-morbid with splenectomy
and any of the above diseases. Splenectomy is associated with a 1.9-fold increased risk of pulmonary tuberculosis in Taiwan. There is a
synergistic effect between splenectomy and other co-morbidities on the risk of pulmonary tuberculosis.
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Introduction
Tuberculosis is a major public health problem because of its
high prevalence and heavy socioeconomic burden. The WHO
estimated that there were 12 million people with tuberculosis
(ranging from 10 to 13 million) in the world in 2011 [1]. The
lungs are the major affected organ, and the resultant disease is
called pulmonary tuberculosis. Epidemiological studies show
that multiple risk factors are associated with pulmonary
tuberculosis, including chronic obstructive pulmonary disease,
pneumoconiosis, chronic kidney diseases, diabetes mellitus,
chronic liver diseases, cancer, human immunodeﬁciency virus
(HIV)/AIDS, tobacco smoking and alcohol consumption [2–4].
Splenectomized patients are at an increased risk for over-
whelming post-splenectomy infections with gram-positive and
gram-negative bacteria [5–7]. To our knowledge, the clinical
association between splenectomy and pulmonary tuberculosis
has not yet been investigated.
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Our biologically plausible hypothesis was that there is a
relationship between splenectomy and pulmonary tuberculo-
sis, so we used the database of the Taiwan National Health
Insurance Programme to investigate this issue.
Materials and Methods
Data sources
This case–control study was designed to analyse the database
of the Taiwan National Health Insurance Programme. Details
of the insurance were described in previous studies [8–10].
Brieﬂy, the National Health Research Institute cooperates
with the Bureau of National Health Insurance to establish
several data ﬁles annually using the National Health Insurance
claims data for administrative use and research. The National
Health Insurance Programme was implemented in 1995,
covering approximately 99% of the whole population of
23.74 million people [11]. This study used two data sets of
1 000 000 individuals randomly selected from all insured
claims data from 1998 to 2011. Diseases were coded based on
the International Classiﬁcation of Disease Diagnoses, 9th
Revision of Clinical Modiﬁcation (ICD-9 codes). The accuracy
and validity of disease diagnosis in the National Health
Insurance Research Database, such as tuberculosis, chronic
obstructive pulmonary disease, chronic kidney diseases,
diabetes mellitus and chronic liver diseases, were demon-
strated in previous studies [9,12–14].
The National Health Research Institute encrypts a patient’s
personal information for privacy protection and provides
researchers with anonymous identiﬁcation numbers associated
with the relevant claim information, which includes the
patient’s sex, date of birth, registry of medical services and
medication prescriptions. Patient consent is not required for
accessing the National Health Insurance Research Database.
The study was also approved by the Institutional Review Board
of China Medical University and Hospital (CMU-REC-
101-012).
Inclusion criteria
In this case–control study, we selected subjects with newly
diagnosed pulmonary tuberculosis as the case group during the
period 1998–2011 based on ICD-9 codes (010, 011, 012 and
018), who were aged 20 years or older at the date of
diagnosis. The index date for each case was the date of
diagnosis of pulmonary tuberculosis. Patients with pulmonary
tuberculosis were identiﬁed at least twice from principal/
secondary diagnoses in outpatient visits or at least once from
hospitalization. For each case, four control subjects were
selected for the control group, who were matched for sex, age
(per 5 years) and index year of pulmonary tuberculosis
diagnosis. Subjects with previous diagnosis of pulmonary
tuberculosis, any cancer or HIV/AIDS before the index date
were excluded.
Potential co-morbidities associated with pulmonary
tuberculosis
A number of co-morbidities before the index date were
examined for their possible association with pulmonary
tuberculosis. These were splenectomy, chronic obstructive
pulmonary disease, pneumoconiosis, chronic kidney diseases,
diabetes mellitus and chronic liver diseases including cirrhosis,
alcoholic liver damage, hepatitis B, hepatitis C and other types
of chronic hepatitis. They were diagnosed using ICD-9 codes.
Statistical analysis
Pulmonary tuberculosis cases were ﬁrst compared with
non-pulmonary tuberculosis controls on their proportional
distributions of demographic status and co-morbidities by
chi-square test for categorical variables and Student’s t test for
continuous variables. Multivariable unconditional logistic
regression analysis was used to estimate the OR and 95% CI
for association between pulmonary tuberculosis and splenec-
tomy, after controlling for age and other co-morbidities. In
addition, we evaluated the interaction effect between sple-
nectomy and other co-morbidities on risk of pulmonary
tuberculosis by using the multivariable unconditional logistic
regression model. All analyses were conducted using the SAS
statistical software (version 9.2 for Windows; SAS Institute,
Inc., Cary, NC, USA), and all statistical tests were performed
at the two-tailed signiﬁcance level of p 0.05.
Results
Characteristics of the study population
There were 18 960 patients with newly diagnosed pulmonary
tuberculosis as the case group and 73 988 subjects without
pulmonary tuberculosis as the control group. Characteristics
and co-morbidities were compared between the pulmonary
tuberculosis group and the non-pulmonary tuberculosis group.
Table 1 shows that the pulmonary tuberculosis group was
more likely to have splenectomy, chronic obstructive pulmo-
nary disease, pneumoconiosis, chronic kidney diseases, diabe-
tes mellitus and chronic liver diseases, with statistical
signiﬁcance. The mean duration from splenectomy to pulmo-
nary tuberculosis diagnosis was 3.93 years (standard deviation
3.76; range 0.07–12.71, data not shown in Table 1).
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Association between splenectomy, co-morbidities and
pulmonary tuberculosis
After adjustment for confounders that were found to be
signiﬁcant in crude analysis, multivariable unconditional logistic
regression analysis showed that the adjusted OR of pulmonary
tuberculosis was 1.91 for splenectomized patients (95% CI
1.06–3.44), compared with non-splenectomized patients. In
addition, chronic obstructive pulmonary diseases (OR 3.07,
95% CI 2.94–3.21), pneumoconiosis (OR 2.20, 95% CI 1.90–
2.56), chronic kidney diseases (OR 1.49, 95% CI 1.33–1.67),
diabetes mellitus (OR 1.57, 95% CI 1.50–1.64) and chronic
liver diseases (OR 1.31, 95% CI 1.25–1.37) were signiﬁcantly
associated with increased risk of pulmonary tuberculosis
(Table 2).
Interaction between splenectomy and other co-morbidities
on risk of pulmonary tuberculosis
As a reference of subjects without splenectomy and without
any co-morbidity, the ORs were 2.60 (95% CI 1.06–6.39) for
those with splenectomy and without any co-morbidity, and as
high as 4.81 (95% CI 2.31–10.0) for those with splenectomy
and presence of any co-morbidity, with statistical signiﬁcance.
Discussion
Although previous literature reported that there was a link
between splenectomy and pulmonary tuberculosis [15,16], to
the best of our knowledge, this is the ﬁrst population-based
study to investigate this relationship. In the present study, we
found that splenectomized patients had 1.9-fold increased risk of
pulmonary tuberculosis. We also found that chronic obstructive
pulmonary diseases, pneumoconiosis, chronic kidney diseases,
diabetes mellitus and chronic liver diseases were signiﬁcantly
associated with increased risk of pulmonary tuberculosis, which
is compatible with previous studies [2–4]. Particularly, the risk
would increase to 4.8-fold for those with splenectomy and
the presence of any of these co-morbidities. We believe that
there is a synergistic effect between splenectomy and other co-
morbidities on risk of pulmonary tuberculosis.
Although the immune response of tuberculosis depends
mostly on cell-mediated immunity, recent evidence has
illustrated that B cells and humoral immunity can play a
modulatory role in the immune response to various intracel-
lular microorganisms, including Mycobacterium tuberculosis [17].
The spleen has a well established fundamental role in
protecting the human body against invading microorganisms
through the bactericidal capacity of lymphoid cells and
macrophages and by the humoral immune response [5–
7,18,19]. The spleen also produces IgM memory B cells, which
are important in protecting against invading microorganisms
[19]. In the absence of the spleen, both phagocytic activities
and the humoral immune response would be markedly
impaired [5–7,19]. We think that altered immune function
caused by splenectomy could potentially precipitate the
development of pulmonary tuberculosis.
Some points should be addressed in the present study. First,
some risk factors of pulmonary tuberculosis, such as tobacco
smoking, alcohol consumption, socioeconomic status and
history of incarceration, were not recorded because of the
inherent limitations of this database. Second, as the result of
the same limitations, we did not know whether cases/controls
received post-splenectomy antibiotic prophylaxis. Third,
although co-morbid conditions were included before the date
of diagnosis of pulmonary tuberculosis, we could not conﬁrm
that these conditions were actually present before the
appearance of tuberculosis symptoms. Fourth, some malig-
nancies, such as leukaemia and lymphoma, can be an indication
for splenectomy and can be an independent risk factor for
pulmonary tuberculosis. To reduce confounding effects, par-
TABLE 1. Characteristics between the pulmonary tubercu-




n = 73 988
Yes
n = 18 960
Sex
Male 48 560 (65.63) 12 431 (65.56) 0.86
Female 25 428 (34.37) 6529 (34.44)
Age group (years)
20–39 13 999 (18.92) 3574 (18.85) 0.98
40–64 28 849 (38.99) 7402 (39.04)
65–84 31 140 (42.09) 7984 (42.11)
Mean (SD) (years) 57.00 (17.23) 57.71 (17.23) <0.0001
Co-morbidities before index date
Splenectomy 31 (0.04) 20 (0.11) 0.0009
Chronic obstructive
pulmonary disease
6542 (8.84) 4409 (23.25) <0.0001
Pneumoconiosis 464 (0.63) 317 (1.67) <0.0001
Chronic kidney diseases 942 (1.27) 536 (2.83) <0.0001
Diabetes mellitus 10 881 (14.71) 4269 (22.52) <0.0001
Chronic liver diseases 8213 (11.10) 3094 (16.32) <0.0001
Data are presented as the number of subjects in each group, with percentages
given in parentheses or mean, with SD given in parentheses.
TABLE 2. Odds ratio and 95% CI of pulmonary tuberculosis
associated with splenectomy and co-morbidities
Variable
Crude Adjusteda
OR (95% CI) OR (95% CI)
Splenectomy 2.53 (1.44–4.44) 1.91 (1.06–3.44)
Chronic obstructive pulmonary disease 3.12 (3.00–3.26) 3.07 (2.94–3.21)
Pneumoconiosis 2.69 (2.33–3.11) 2.20 (1.90–2.56)
Chronic kidney diseases 2.26 (2.03–2.51) 1.49 (1.33–1.67)
Diabetes mellitus 1.69 (1.62–1.75) 1.57 (1.50–1.64)
Chronic liver diseases 1.56 (1.49–1.63) 1.31 (1.25–1.37)
aAdjusted for age, chronic obstructive pulmonary disease, pneumoconiosis,
chronic kidney diseases, diabetes mellitus and chronic liver diseases.
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ticipants with a diagnosis of any cancer or HIV/AIDS before the
index date were excluded from the study. The strength of this
present study is that the set of ICD-9 codes used has been
validated in previous published studies [8–10,12–14]. The
present study was based on a biologically plausible hypothesis
and its long-term follow up allowed for a valid assessment of
the time course from splenectomy to diagnosis of pulmonary
tuberculosis. This study used a large population-based data-
base that strengthens the power of the ﬁndings.
We conclude that splenectomy is associated with 1.9-fold
increased risk of pulmonary tuberculosis in Taiwan. The risk
increases to 4.8-fold for those with splenectomy and the
presence of any co-morbidity. Based on these ﬁndings, regular
surveillance for pulmonary tuberculosis can be recommended
for patients with splenectomy and other co-morbidities.
Further prospective studies are needed to conﬁrm our ﬁndings.
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